Cargando…

PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling

BACKGROUND: Phospholipase C Delta 3 (PLCD3) is a member of phospholipase C(PLC) Protein and PLCD3 protein plays a prominent role in many cancers. However, little is known about the role of PLCD3 in esophageal squamous cell carcinoma (ESCC). MATERIAL AND METHODS: We analyzed PLCD3 mRNA and protein ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mengmeng, Gao, Mingjun, Chen, Yong, Wu, Jun, Wang, Xiaolin, Shu, Yusheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542242/ https://www.ncbi.nlm.nih.gov/pubmed/37773107 http://dx.doi.org/10.1186/s12885-023-11409-w

Ejemplares similares

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway
por: Qiao, Zhongshi, et al.
Publicado: (2022)

Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway
por: ZHANG, HONG-BO, et al.
Publicado: (2013)

ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway
por: Yin, Hui, et al.
Publicado: (2020)

TET3 governs malignant behaviors and unfavorable prognosis of esophageal squamous cell carcinoma by activating the PI3K/AKT/GSK3β/β-catenin pathway
por: Zhu, Maoling, et al.
Publicado: (2022)

CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
por: Jia, Yang, et al.
Publicado: (2018)

HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma
por: Zhang, Xueyuan, et al.
Publicado: (2022)

Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma
por: Hu, Hai, et al.
Publicado: (2023)

PLCD3, a flotillin2-interacting protein, is involved in proliferation, migration and invasion of nasopharyngeal carcinoma cells
por: Liu, Weidong, et al.
Publicado: (2018)

The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma
por: Wu, Ning, et al.
Publicado: (2018)

HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
por: Wang, Hongqiang, et al.
Publicado: (2019)

XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway
por: Jian, Jie, et al.
Publicado: (2020)

Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
por: Hu, Dong-Xin, et al.
Publicado: (2022)

Ailanthone Inhibits Cell Proliferation in Tongue Squamous Cell Carcinoma via PI3K/AKT Pathway
por: Wang, Shuhan, et al.
Publicado: (2022)

MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis
por: Yin, Shuhong, et al.
Publicado: (2021)

MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway
por: Wang, Zekun, et al.
Publicado: (2023)

circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway
por: Zhou, Shifan, et al.
Publicado: (2021)

Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway
por: Shen, Zhipeng, et al.
Publicado: (2017)

miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
por: Zheng, Tian-Liang, et al.
Publicado: (2019)

PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
por: Luo, Qian, et al.
Publicado: (2022)

Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway
por: Hui, Beina, et al.
Publicado: (2021)

Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy
por: Li, Bin, et al.
Publicado: (2017)

MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis [Retraction]
Publicado: (2023)

Alisol A attenuates malignant phenotypes of colorectal cancer cells by inactivating PI3K/Akt signaling
por: Han, Weiwei, et al.
Publicado: (2022)

The effects of HBXIP on the biological functions of tongue squamous cell carcinoma cells and correlation with PI3K/Akt
por: Meng, Xue, et al.
Publicado: (2020)

AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway
por: Zhang, Zhan‐Fei, et al.
Publicado: (2020)

Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways
por: Kong, Lingming, et al.
Publicado: (2020)

Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma
por: Tian, Baoqing, et al.
Publicado: (2017)

CACNA2D3 Enhances the Chemosensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin via Inducing Ca(2+)-Mediated Apoptosis and Suppressing PI3K/Akt Pathways
por: Nie, Changjun, et al.
Publicado: (2019)

Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway
por: Wang, Xuyang, et al.
Publicado: (2019)

Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down‐regulating PI3K/AKT pathway
por: Wang, Chenjie, et al.
Publicado: (2019)

Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
por: Jiang, Ningni, et al.
Publicado: (2020)

Elevated HNF1A expression promotes radiation-resistance via driving PI3K/AKT signaling pathway in esophageal squamous cell carcinoma cells
por: Zou, Naiyi, et al.
Publicado: (2021)

Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma
por: Fan, Zhiqin, et al.
Publicado: (2023)

LSD1 regulates Notch and PI3K/Akt/mTOR pathways through binding the promoter regions of Notch target genes in esophageal squamous cell carcinoma
por: Hou, Guiqin, et al.
Publicado: (2019)

Identification of two novel mutations in the PLCD1 gene in Chinese patients with hereditary leukonychia
por: Shen, Shuzhan, et al.
Publicado: (2021)

Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression
por: Dou, Xiao-Lin, et al.
Publicado: (2023)

Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma
por: Wang, Bo, et al.
Publicado: (2022)

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4fkvkmlsgm5lbshh6rc2oru5s0